Medical School: Imperial College School of Medicine
Residency: Tufts Medical Center
- American Board of Internal Medicine (ABIM)
- Member of Royal College of Physicians of London (MRCP)
Research and Career Path
I am a board-certified internal medicine physician and entered my clinical fellowship having completed general internal medicine training both in the U.K. and U.S. in addition to obtaining an NIH funded master’s degree in clinical and translational science. My research interests lie in the use of clinical risk prediction tools to personalize patient care. I am currently on an NIH funded benign hematology T32 training grant, working with my mentors Dr. Nigel Key and Dr. Katherine Reeder-Hayes in looking at risk prediction tools and large database analyses in the field of cancer associated thrombosis.
1. Illich A*, Kumar V*, Henderson M, Mallick R, Wells P, Carrier M, Key N. Biomarkers in cancer patients at risk of venous thromboembolism: data from the AVERT study. In press Thrombosis Research Feb 2020. *co-first author
2. Kumar V, Eulitt PJ, Bermudez A, Khagi S. Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case report. CNS Oncol. 2019 Dec 1;8(4) CNS45
3. Kumar V, Cohen J, vanKlaveren D, Soteman D, Wong J, Neumann P, Kent D. Risk-targeted Lung Cancer Screening: A Cost-effectiveness analysis. Annals of Internal Medicine 2018; 168(3): 161-169
4. Kumar V. A tale of two countries. Annals of Internal Medicine 2017; 167(9):686.
5. Kumar V, Santhanakrishnan K. Obstructing Broncholith. Lancet. 2013; 382(9903):1534
6. Charron CE, Chou PC, Coutts DJC, Kumar V, To M, Akashi K, Barnes PJ, Ito K. Hypoxia-inducible Factor 1 alpha Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription. J BIOL CHEM. 2009; 284:36047-36054.